-
Survivor Profile
Changing CourseInitially diagnosed with ductal carcinoma in situ, Sabrina Mayhew’s persistence in seeking out experts would lead to tumor testing that indicated she could safely forgo chemotherapy.
by Queen Muse
-
Healthy Habits
Make Time for TeaA daily tea habit is associated with improved survival for those with colorectal cancer.
by Anne Danahy
-
Q&A
Pulling Back the Research CurtainJessica Wapner looks back on the scientific discoveries that transformed outcomes for chronic myelogenous leukemia.
by Marci A. Landsmann
-
Lung Cancer Patients Face Worse Survival After Wildfire ExposureResearchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.
by Sandra Gordon
-
Choosing Between Lung Cancer Surgery and RadiationStudy suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.
by Jon Kelvey
-
Understanding Disparities in Melanoma DiagnosisBlack men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.
by Kyle Bagenstose
-
After Colorectal Cancer, Survivors Face Higher Risk for a Second CancerResearchers find increased risk of four types of secondary cancer in patients diagnosed with early-onset colorectal cancer.
by Sandra Gordon
-
Sunscreen Is Just the StartExperts say protection against UV rays and watching for changes in your skin are important tools in skin cancer risk prevention.
by Kyle Bagenstose
-
Ovarian Cancer: A Quest to Extend RemissionsNew treatments aim to lengthen remissions and push back recurrences.
by Erin O’Donnell
-
Survivor Profile
Educator and AdvocateFormer teacher Peggy Zuckerman helps others by sharing her experiences with stage IV kidney cancer.
by Kristin Baird Rattini
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
